- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4052EUR$4,490USD£3,520GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1128EUR$1,250USD£980GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1128EUR$1,250USD£980GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1128EUR$1,250USD£980GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1805EUR$2,000USD£1,568GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1354EUR$1,500USD£1,176GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1805EUR$2,000USD£1,568GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1354EUR$1,500USD£1,176GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1354EUR$1,500USD£1,176GBP
- Report
- January 2026
- 180 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- January 2026
- 185 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- June 2025
- 150 Pages
Global
From €2436EUR$2,699USD£2,116GBP
- Report
- June 2025
- 200 Pages
Global
From €2517EUR$2,789USD£2,187GBP
- Report
- February 2026
- 160 Pages
Global
From €2996EUR$3,320USD£2,603GBP
€3745EUR$4,150USD£3,254GBP
- Report
- August 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- July 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- May 2025
- 134 Pages
Global
From €16240EUR$17,995USD£14,109GBP
- Report
- August 2025
- 98 Pages
Global
From €4377EUR$4,850USD£3,803GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more